Access Programs
214 programsSingapore Special Access Route
Framework: Health Products Act
Patient with serious or life-threatening condition, no registered alternative available
Special Access7d
Solomon Islands Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program60d
Somalia Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program60d
South Africa Section 21 Access Program
Framework: Medicines and Related Substances Act
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program30d
South Sudan Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program60d
Spain Uso Compasivo Program
Framework: Real Decreto 1015/2009
Patient with serious or life-threatening condition, no registered alternative available
Compassionate Use30d
Special Access Program – Canada
Framework: Food and Drug Regulations C.08.010
Patient with serious or life-threatening condition, no registered alternative available
Special Access5d
Sri Lanka Named Patient Program
Framework: NMRA Act
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program21d
Sudan Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program45d
Suriname Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program45d
Sweden Licensläkemedel Program
Framework: Läkemedelslagen
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program14d
Switzerland Compassionate Use Program
Framework: Therapeutic Products Act (HMG)
Patient with serious or life-threatening condition, no registered alternative available
Compassionate Use30d
Syria Named Patient Program
Framework: Syrian Drug Regulations
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program45d
Tajikistan Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program45d
Tanzania Named Patient Program
Framework: Tanzania Food, Drugs and Cosmetics Act
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program30d
TGA Special Access Scheme – Australia
Framework: Therapeutic Goods Act 1989
Patient with serious or life-threatening condition, no registered alternative available
Special Access28d
Thailand Named Patient Program
Framework: Drug Act B.E. 2510
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program30d
Timor-Leste Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program60d
Togo Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program45d
Tonga Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program60d
Trinidad and Tobago Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program30d
Tunisia Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program45d
Turkey Compassionate Use Program
Framework: Law No. 1262 on Pharmaceuticals
Patient with serious or life-threatening condition, no registered alternative available
Compassionate Use21d
Turkmenistan Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program45d
Tuvalu Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program60d